These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 37291088)
1. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis. Hong SY; Lu YT; Chen SY; Hsu CF; Lu YC; Wang CY; Huang KL Cell Death Dis; 2023 Jun; 14(6):352. PubMed ID: 37291088 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice. Chen Y; Wang T; Liang F; Han J; Lou Z; Yu Y; Li J; Zhan T; Gu Y; Dong L; Jiang B; Zhang W; Wu M; Lu Y Theranostics; 2024; 14(7):2794-2815. PubMed ID: 38773984 [No Abstract] [Full Text] [Related]
3. Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling. Liu B; Jiang Q; Chen R; Gao S; Xia Q; Zhu J; Zhang F; Shao C; Liu X; Li X; Zhou H; Yang C; Huang H Int Immunopharmacol; 2022 Dec; 113(Pt A):109424. PubMed ID: 36461589 [TBL] [Abstract][Full Text] [Related]
4. Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program. Deng L; Ouyang B; Tang W; Wang N; Yang F; Shi H; Zhang Z; Yu H; Chen M; Wei Y; Dong J Phytomedicine; 2024 Jul; 130():155687. PubMed ID: 38759312 [TBL] [Abstract][Full Text] [Related]
5. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis. Choi SM; Mo Y; Bang JY; Ko YG; Ahn YH; Kim HY; Koh J; Yim JJ; Kang HR Respir Res; 2023 Mar; 24(1):68. PubMed ID: 36870972 [TBL] [Abstract][Full Text] [Related]
6. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization. Deng L; Ouyang B; Shi H; Yang F; Li S; Xie C; Du W; Hu L; Wei Y; Dong J J Ethnopharmacol; 2023 Dec; 317():116810. PubMed ID: 37331450 [TBL] [Abstract][Full Text] [Related]
7. Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization. Bao J; Liu C; Song H; Mao Z; Qu W; Yu F; Shen Y; Jiang J; Chen X; Wang R; Wang Q; Chen W; Zheng S; Chen Y BMC Pulm Med; 2024 Sep; 24(1):444. PubMed ID: 39261812 [TBL] [Abstract][Full Text] [Related]
8. Technical advance: The use of tree shrews as a model of pulmonary fibrosis. Larson-Casey JL; He C; Che P; Wang M; Cai G; Kim YI; El Hamdaoui M; Grytz R; Ding Q; Carter AB PLoS One; 2020; 15(11):e0241323. PubMed ID: 33141839 [TBL] [Abstract][Full Text] [Related]
9. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation. Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages. Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577 [TBL] [Abstract][Full Text] [Related]
11. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis. Hou J; Shi J; Chen L; Lv Z; Chen X; Cao H; Xiang Z; Han X Cell Commun Signal; 2018 Nov; 16(1):89. PubMed ID: 30470231 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosis. Choi I; Han IH; Cha N; Kim HY; Bae H Biomed Pharmacother; 2024 Sep; 178():117246. PubMed ID: 39096617 [TBL] [Abstract][Full Text] [Related]
14. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation. Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453 [TBL] [Abstract][Full Text] [Related]
15. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway. Zhu L; Fu X; Chen X; Han X; Dong P Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530 [TBL] [Abstract][Full Text] [Related]
16. Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarization. Zhang R; Jiang Q; Gao S; Zhang H; Xia Q; Liu B; Zhu J; Jiang H; Zhao R; Dong H; Li X; Zhang Y; Yang C; Gu X; Sun L; Zhou H Int Immunopharmacol; 2024 Apr; 131():111774. PubMed ID: 38489971 [TBL] [Abstract][Full Text] [Related]
17. Clevudine attenuates bleomycin-induced early pulmonary fibrosis via regulating M2 macrophage polarization. Li S; Gao S; Jiang Q; Liang Q; Luan J; Zhang R; Zhang F; Ruan H; Li X; Li X; Zhou H; Yang C Int Immunopharmacol; 2021 Dec; 101(Pt B):108271. PubMed ID: 34700113 [TBL] [Abstract][Full Text] [Related]
18. Role of transient receptor potential ankyrin 1 in idiopathic pulmonary fibrosis: modulation of M2 macrophage polarization. Yang Y; Xiao Z; Yang W; Sun Y; Sui X; Lin X; Yang X; Bao Z; Cui Z; Ma Y; Li W; Wang S; Yang J; Wang Y; Luo Y Cell Mol Life Sci; 2024 Apr; 81(1):187. PubMed ID: 38635081 [TBL] [Abstract][Full Text] [Related]
19. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production. Clark JG; Kostal KM; Marino BA J Clin Invest; 1983 Dec; 72(6):2082-91. PubMed ID: 6196378 [TBL] [Abstract][Full Text] [Related]
20. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis. Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]